Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet’s Disease

Current and future treatments for Behçet’s uveitis: road to remission

(2013) Marina Mesquida et al.   INTERNATIONAL OPHTHALMOLOGY

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

(2012) Sunao Sugita et al.   ARTHRITIS RESEARCH & THERAPY

Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow

(2011) Blanca Molins et al.   CARDIOVASCULAR RESEARCH

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

(2010) Nobuhisa Mizuki et al.   NATURE GENETICS

Genome-wide association study identifies variants in the MHC class I, IL10 and IL23R-IL12RB2 regions associated with Behçet's disease

(2010) Elaine F Remmers et al.   NATURE GENETICS

Etiopathogenesis of Behcet's disease

(2009) Claudia Mendoza-Pinto et al.   AUTOIMMUNITY REVIEWS

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behcet disease

(2009) Y. Yamada et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Clinical Review: Anti-TNFα Therapies in Uveitis: Perspective on 5 Years of Clinical Experience

(2009) Srilakshmi M. Sharma et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

EULAR recommendations for the management of Behcet disease

(2008) G Hatemi et al.   ANNALS OF THE RHEUMATIC DISEASES

C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth

(2008) Blanca Molins et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Behçet's disease: Ocular effects and treatment

(2007) C DEUTER et al.   PROGRESS IN RETINAL AND EYE RESEARCH